|
| | 1,2,4-butanetriol-3-(1,4,7,10-tetraazacyclododec-1-yl)4hydrochloride Basic information |
| Product Name: | 1,2,4-butanetriol-3-(1,4,7,10-tetraazacyclododec-1-yl)4hydrochloride | | Synonyms: | 1,2,4-butanetriol-3-(1,4,7,10-tetraazacyclododec-1-yl)4hydrochloride;3-(1,4,7,10-tetraazacyclododecan-1-yl)butan-1,2,4-triol HCl;3-(1,4,7,10-tetraazacyclododecan-1-yl)butan-1,2,4-triol 4HCl;3-(1,4,7,10-tetraazacyclododecan-1-yl)butan-1,2,4-triol HC;3-(1,4,7,10-Tetraazacyclododec-1-yl)-1,2,4-butanetriol hydrochloride (1:4);1,2,4-butanetriol-3-(1,4,7,10-tetraazacyclododec-1-yl)4hydro...;GDB1;3-(1,4,7,10-Tetraazacyclododecan-1-yl)butane-1,2,4-triol tetrahydrochloride | | CAS: | 156077-56-4 | | MF: | C12H29ClN4O3 | | MW: | 312.84 | | EINECS: | | | Product Categories: | | | Mol File: | 156077-56-4.mol |  |
| | 1,2,4-butanetriol-3-(1,4,7,10-tetraazacyclododec-1-yl)4hydrochloride Chemical Properties |
| | 1,2,4-butanetriol-3-(1,4,7,10-tetraazacyclododec-1-yl)4hydrochloride Usage And Synthesis |
| Uses | 1,2,4-butanetriol-3-(1,4,7,10-tetraazacyclododec-1-yl)4hydrochloride is an intermediate that manufacture gadobutrol . gadobutrol is a gadolinium-based contrast agent indicated for intravenous use in diagnostic MRI in adults and children (2 years of age and older) to detect and visualize areas with disrupted blood brain barrier (BBB) and/or abnormal vascularity of the central nervous system. |
| | 1,2,4-butanetriol-3-(1,4,7,10-tetraazacyclododec-1-yl)4hydrochloride Preparation Products And Raw materials |
|
